Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Novel gene therapy reverses atherosclerotic process in mice

Feb. 17, 2000

German researchers disclose new agents for hypertension

Feb. 16, 2000

FDA grants Merck & Co. marketing exclusivity extension for Vasotec

Feb. 16, 2000

Potent and selective ETA antagonist selected as development candidate

Feb. 15, 2000

Millennium uncovers role of Madh6 gene in cardiovascular defects

Feb. 15, 2000

Novel Warner-Lambert compounds act as inhibitors of Lp(a) production

Feb. 14, 2000

Dual AT1/ETA receptor antagonists from BMS, their preparation, use and pharmaceutical compositions

Feb. 11, 2000

Start of phase II trials for Resten-NG announced

Feb. 11, 2000

Enrollment in phase I study of Avant's CETP vaccine now complete

Feb. 8, 2000

Boehringer Ingelheim seeks approval for combination hypertension treatments

Feb. 8, 2000

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...